Does Pandemic Anxiety Affect Urology Health Care Workers?


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2021
Historique:
received: 04 07 2020
accepted: 04 11 2020
pubmed: 22 1 2021
medline: 11 3 2021
entrez: 21 1 2021
Statut: ppublish

Résumé

To assess anxiety, stress level, and perception of safety during the coronavirus disease 2019 (COVID-19) pandemic in health care workers (HCWs) of one of Germany's largest urology university clinics. A cross-sectional study among urological HCWs was performed. HCWs were surveyed for anxiety about the pandemic, stress level and current workload, fear of coronavirus infection, current perception of safety at work, and attitude towards protective equipment and tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Sixty-three HCWs filled in the questionnaire. Overall anxiety of infection with CO-VID-19 is at a median of 4.7 with no statistically significant difference between nurses and physicians (p = 0.0749). Safety at work reaches a median of 6 out of 10. In fact, the highest fear in 56.7% (31/63) of the personnel is to get infected by a colleague tested positive for SARS-CoV-2 despite wearing surgical face masks. A proportion of 55.7 and 74.6% highly favor swabs for SARS-CoV-2 on a regular basis in HCWs and patients, respectively (p = 0.0001). Workload in the urology department is clearly reduced during the pandemic (physicians 39.3% vs. nurses 32.2%, p = 0.0001) and 57.4% do not feel distress at all; only 27.9% express mental distress. During the pandemic, urology HCWs perceive lower burden by workload and deem themselves at low risk of infection. However, the greatest anxiety is related to infection by a SARS-CoV-2-positive colleague, despite reciprocal protection by surgical face masks. This highlights a relevant mental stress and uncertainty towards management of infected HCWs, calling for increased education and psychological support.

Identifiants

pubmed: 33477161
pii: 000512911
doi: 10.1159/000512911
pmc: PMC7900483
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

192-198

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Maria Apfelbeck (M)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Michael Staehler (M)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Severin Rodler (S)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Regina Stredele (R)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Michael Chaloupka (M)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Jan-Niclas Mumm (JN)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Alexander Buchner (A)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Christian Stief (C)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Jozefina Casuscelli (J)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany, Jozefina.casuscelli@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH